FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013057100> ?p ?o ?g. }

• W2013057100 endingPage "200" @default.
• W2013057100 startingPage "192" @default.
• W2013057100 abstract "Aim To investigate the relationship between the serum levels of CEA, CA19-9, CA24-2, CA72-4, and AFP in patients with gastric cancer (GC) and their clinicopathological characteristics; to analyze the efficacy of these tumor markers in evaluating the prognosis of GC. Methods Overall, 389 patients with GC either located in the gastric cardia (132), the pyloric antrum (112) or the body of the stomach (145) were included in the study. Serum levels of CEA, CA19-9, CA72-4, and AFP were detected with the ECLIA method, while CA24-2 was measured with ELISA. Results First, the serum level of CEA in GC patients with a cardia-located cancer was significantly higher than in patients with pyloric antrum-located cancer (p=0.050). CA72-4 level in patients with GC located in the gastric body was significantly higher than in patients with cardia and pyloric antrum-located cancers (p=0.042 and p=0.039, respectively). Secondly, serum CA19-9 and CA24-2 levels in females with cardia-located GC were significantly higher than those in males with the same type of tumor (p=0.037 and p=0.033, respectively). Additionally, for females with gastric body-located GC the levels of CEA and CA72-4 were significantly higher than those in male patients with the same type of tumor (p=0.047 and p=0.048, respectively). Conversely, in female GC patients with pyloric antrum-located cancer the serum levels of CA19-9 and CA24-2 were significantly lower than those in male patients with the same type of cancer (p=0.013 and p=0.007, respectively). Moreover, CEA, CA19-9, CA24-2, and CA72-4 levels were strongly related to TNM grade and histological anatomy stage, whereas CEA and CA72-4 levels were strongly related to lymph node stage (p=0.000 and p=0.042, respectively). Patients with vascular embolism had higher serum levels of CEA, CA19-9, CA24-2, and CA72-4 compared with patients without vascular embolism (p=0.005, p=0.031, p=0.007, and p=0.014, respectively). In patients with distant metastases and ascites the levels of CEA, CA19-9, and CA24-2 were higher than in patients without these conditions (p=0.003, p=0.001, p=0.001, p=0.016, p= 0.011, and p=0.030, respectively). Serum CEA, CA19-9, and CA24-2 levels showed correlations with tumor invasive depth and growth types (p=0.001, p=0.040, and p=0.035, respectively). Patients with lump and catheter tumor growth types had significantly higher AFP levels than patients with invasion and anabrosis growth types (p=0.034 and p=0.005, respectively). Tumor size was correlated with the preoperative serum levels of CEA, AFP, and CA72-4 (p=0.007, p=0.020, and p=0.008, respectively). Additionally multiple linear regression analysis showed that preoperative levels of CEA and CA72-4 were correlated to TNM stages, CA19-9 and CA24-2 levels were correlated to both gender and distant metastasis, and AFP was correlated only to ascites. During follow-up there were 115 deaths. Median survival time for GC patients with negative preoperative CEA was 18.07 months, and was 10.97 months for patients with preoperative CEA positive levels (p=0.0005). Similarly, the median survival time for GC patients with negative preoperative CA72-4 was 33.60, and was 16.03 months for patients with preoperative CA72-4 positive levels (p=0.0041). Conclusions The preoperative levels of CEA, CA19-9, CA24-2, CA72-4, and AFP were closely related to TNM grade, gender, distant metastasis and ascites. These makers seem to play important roles in predicting recurrence and metastasis, and in evaluating prognosis." @default.
• W2013057100 created "2016-06-24" @default.
• W2013057100 creator A5003234602 @default.
• W2013057100 creator A5032003471 @default.
• W2013057100 creator A5054086672 @default.
• W2013057100 creator A5062045949 @default.
• W2013057100 creator A5072271439 @default.
• W2013057100 creator A5072667148 @default.
• W2013057100 creator A5087034276 @default.
• W2013057100 date "2013-04-01" @default.
• W2013057100 modified "2023-10-03" @default.
• W2013057100 title "Clinical Assessment and Prognostic Evaluation of Tumor Markers in Patients with Gastric Cancer" @default.
• W2013057100 cites W1970496820 @default.
• W2013057100 cites W1971838028 @default.
• W2013057100 cites W1972000098 @default.
• W2013057100 cites W1977499361 @default.
• W2013057100 cites W1981127049 @default.
• W2013057100 cites W1999657585 @default.
• W2013057100 cites W2003990839 @default.
• W2013057100 cites W2004607039 @default.
• W2013057100 cites W2009623911 @default.
• W2013057100 cites W2015007116 @default.
• W2013057100 cites W2021097837 @default.
• W2013057100 cites W2025862299 @default.
• W2013057100 cites W2027157763 @default.
• W2013057100 cites W2028922282 @default.
• W2013057100 cites W2029009269 @default.
• W2013057100 cites W2030674460 @default.
• W2013057100 cites W2033810423 @default.
• W2013057100 cites W2034623277 @default.
• W2013057100 cites W2036662311 @default.
• W2013057100 cites W2037610580 @default.
• W2013057100 cites W2041450700 @default.
• W2013057100 cites W2042088753 @default.
• W2013057100 cites W2049482244 @default.
• W2013057100 cites W2060624539 @default.
• W2013057100 cites W2064135404 @default.
• W2013057100 cites W2064777734 @default.
• W2013057100 cites W2065467356 @default.
• W2013057100 cites W2071215806 @default.
• W2013057100 cites W2073859876 @default.
• W2013057100 cites W2074061932 @default.
• W2013057100 cites W2081108170 @default.
• W2013057100 cites W2093178060 @default.
• W2013057100 cites W2105423180 @default.
• W2013057100 cites W2110458679 @default.
• W2013057100 cites W2120242031 @default.
• W2013057100 cites W2121326508 @default.
• W2013057100 cites W2135092420 @default.
• W2013057100 cites W2145230394 @default.
• W2013057100 cites W2157296556 @default.
• W2013057100 cites W2169440860 @default.
• W2013057100 cites W2395183591 @default.
• W2013057100 cites W2400288300 @default.
• W2013057100 cites W2401183345 @default.
• W2013057100 cites W2405275786 @default.
• W2013057100 cites W3185425590 @default.
• W2013057100 doi "https://doi.org/10.5301/jbm.5000023" @default.
• W2013057100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23787496" @default.
• W2013057100 hasPublicationYear "2013" @default.
• W2013057100 type Work @default.
• W2013057100 sameAs 2013057100 @default.
• W2013057100 citedByCount "34" @default.
• W2013057100 countsByYear W20130571002013 @default.
• W2013057100 countsByYear W20130571002014 @default.
• W2013057100 countsByYear W20130571002015 @default.
• W2013057100 countsByYear W20130571002016 @default.
• W2013057100 countsByYear W20130571002017 @default.
• W2013057100 countsByYear W20130571002018 @default.
• W2013057100 countsByYear W20130571002019 @default.
• W2013057100 countsByYear W20130571002020 @default.
• W2013057100 countsByYear W20130571002021 @default.
• W2013057100 countsByYear W20130571002022 @default.
• W2013057100 crossrefType "journal-article" @default.
• W2013057100 hasAuthorship W2013057100A5003234602 @default.
• W2013057100 hasAuthorship W2013057100A5032003471 @default.
• W2013057100 hasAuthorship W2013057100A5054086672 @default.
• W2013057100 hasAuthorship W2013057100A5062045949 @default.
• W2013057100 hasAuthorship W2013057100A5072271439 @default.
• W2013057100 hasAuthorship W2013057100A5072667148 @default.
• W2013057100 hasAuthorship W2013057100A5087034276 @default.
• W2013057100 hasBestOaLocation W20130571001 @default.
• W2013057100 hasConcept C121608353 @default.
• W2013057100 hasConcept C126322002 @default.
• W2013057100 hasConcept C131253125 @default.
• W2013057100 hasConcept C144369459 @default.
• W2013057100 hasConcept C2779422922 @default.
• W2013057100 hasConcept C2779454504 @default.
• W2013057100 hasConcept C2780210213 @default.
• W2013057100 hasConcept C2781447364 @default.
• W2013057100 hasConcept C2910480513 @default.
• W2013057100 hasConcept C3017563778 @default.
• W2013057100 hasConcept C71924100 @default.
• W2013057100 hasConcept C90924648 @default.
• W2013057100 hasConceptScore W2013057100C121608353 @default.
• W2013057100 hasConceptScore W2013057100C126322002 @default.
• W2013057100 hasConceptScore W2013057100C131253125 @default.
• W2013057100 hasConceptScore W2013057100C144369459 @default.

• next